STUDY TO COMPARE THE EFFICACY AND SAFETY OF ENZYME REPLACEMENT THERAPIES NEOGAA AND ALGLUCOSIDASE ALFA ADMINISTERED EVERY OTHER WEEK IN PATIENTS WITH LATE-ONSET POMPE DISEASE WHO HAVE NOT BEEN PREVIOUSLY TREATED FOR POMPE DISEASE: